News
The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated ...
The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...
The U.S. health regulator has allowed a study of Rocket Pharmaceuticals' gene therapy to resume, less than three months after ...
The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...
The hits just keep on coming for Regeneron’s Eylea franchise. | The FDA has extended its target action dates for two ...
In its advisory warning about the potential contamination, the FDA noted that although the nuclear byproduct Cesium-137 (Cs ...
A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The ...
E (Nasdaq:NVNO) announced today that it received a not-approvable letter from the FDA related to its VenoValve.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results